We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials (323783)
ARTG ID 323783
ARTG Name
CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials
Product name
CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
cabotegravir
rilpivirine
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information